Driven by increased demand, the PACS market is expected to grow at a compound annual growth rate (CAGR) of 12% from 2006-2011, according to a new report issued by market research firm Research and Markets.
The clinical benefits of PACS are a basis for strong growth, as the technology enables clinicians to provide a higher level of patient care, according to the Dublin, Ireland-based firm. In other findings, the company said that the market is now largely dominated by institutions seeking a singular RIS/PACS network.
The U.S. market is now predominately focused on small community hospitals, while the Nordic countries and the U.K. will still show some growth despite being mature markets, Research and Market said. Germany and France also demonstrate large growth potential.
By AuntMinnie.com staff writers
September 10, 2007
Related Reading
Study: U.S. medical device market will reach $246 billion, February 9, 2007
Study: Global molecular therapies market tops $7 billion, October 27, 2006
Copyright © 2007 AuntMinnie.com
